[Intermediate outcomes of alumina-on-alumina bearing total hip arthroplasty]

Zhonghua Yi Xue Za Zhi. 2011 Dec 20;91(47):3316-9.
[Article in Chinese]

Abstract

Objective: To explore the intermediate outcomes of third-generation alumina-on-alumina total hip arthroplasty (THA).

Methods: A consecutive series of 165 primary alumina-on-alumina total hip arthroplasties were performed in 135 patients. Three patients died and 13 patients lost follow-up so that a total of 119 patients (146 hips) were available for study. The mean patient age was 53.4 ± 11.0 years old (range: 26 - 79). Hydroxyapatite. (HA)-coated press-fit acetabular cups were used in all cases. At femoral side, 123 cases were implanted with HA-coated uncemented stems and 23 cases implanted with high polished double taped cemented stems. All patients were evaluated clinically and radiographically after a minimal follow-up duration of 60 months.

Results: The preoperative mean Harris hip score of 49.6 ± 7.9 points improved to 91.7 ± 3.0 points at the last follow-up (P < 0.05). The 5-year survival for any reason lead to revision was 96.6%. Five hips were under revision, 1 for acetabular shell loosening and migration, 1 for Vancouver B2 periprosthetic fracture, 1 for fracture of pure alumina liner and 2 for infections. All other prostheses demonstrated no radiographic evidence of loosening. No periprosthetic osteolysis was found. There were 2 cases of dislocations and 2 patients presented postoperatively with "squeaking-like" hips.

Conclusion: The clinical and radiographic outcomes after primary THA with third-generation ceramic-on-ceramic bearing surfaces are favorable after a minimal follow-up duration of 5 years. The modified alumina-on-alumina bearing implants offer a better option for younger and active patients.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aluminum Oxide*
  • Arthroplasty, Replacement, Hip / instrumentation*
  • Ceramics*
  • Female
  • Hip Prosthesis*
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Design
  • Treatment Outcome

Substances

  • Aluminum Oxide